• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nanoparticles

Nanobiotix reels in $18.5m tranche from European Investment Bank

October 17, 2018 By Sarah Faulkner

Nanobiotix

Nanobiotix (PAR:NANO.PA) received €16 million ($18.5 million) in the first tranche of a previously-announced non-dilutive loan from the European Investment Bank. The five-year funding deal is designed to support the company’s development of nanoparticle-based cancer therapies. Nanobiotix is specifically charged with bringing its NBTXR3 product through a clinical development program in patients with head and neck […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Nanoparticles, Oncology, Pharmaceuticals, Wall Street Beat Tagged With: nanobiotix

How suppliers are taking drug-delivery tech to the next level

September 14, 2018 By Heather Thompson

ProMed Pharma medtech suppliers drug delivery tech

Medical device industry suppliers and outsourcers are helping to enable the latest drug-delivery tech. Drug-eluting technologies are moving beyond stents, thanks in part to the development of polymeric hydrogels engineered to respond to a range of different physical and chemical stimuli. Medtech innovators have figured out how to use hydrogels as components of micro-shells or […]

Filed Under: Contract Services, Discovery, Drug-Device Combinations, Featured, Hydrogels, Nanoparticles, Stents Tagged With: Freudenberg Sealing Technologies, freudenbergmedical, freudenbergmedicalhemoteq, lubrizol, promedpharma, Trelleborg, Trelleborg Sealing Solutions

Researchers use microparticles for targeted delivery of brain cancer therapy

August 7, 2018 By Sarah Faulkner

MIT - Glioma therapy

A team of researchers from Brigham & Women’s Hospital, Mass. Institute of Technology and Mass. General Hospital demonstrated that localizing the delivery of NAMPT inhibitors can extend survival in a mouse model of glioma, according to a paper published this week in the Proceedings of the National Academy of Sciences. The scientists created a test to […]

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Oncology, Pharmaceuticals, Research & Development Tagged With: Brigham & Women's Hospital, Massachusetts General Hospital, Massachusetts Institute of Technology

Nanobiotix inks $47m financing to support nanomedicine development

July 30, 2018 By Sarah Faulkner

Nanobiotix nanoparticle

Nanobiotix (PAR:NANO.PA) inked a non-dilutive financial deal with the European Investment Bank last week to support the development of its nanoparticle-based cancer therapies. The Paris, France-based company said it landed a five-year loan to borrow up to €40 million ($46.7 million) contingent upon a set of performance milestones. Nanobiotix plans to use the funds to bring its NBTXR3 […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Nanoparticles, Oncology, Pharmaceuticals, Wall Street Beat Tagged With: nanobiotix

Takeda, leon-nanodrugs ink feasibility testing deal for reformulated drug

July 17, 2018 By Sarah Faulkner

Takeda, Leon Nanodrugs

leon-nanodrugs said today that Takeda (TYO:4502) tapped its MicroJet Reactor technology as part of a feasibility study that could result in the reformulation of one of Takeda’s pipeline products. Using leon’s nanotechnology platform, the companies plan to boost the solubility, bioavailability and stability of one of Takeda’s pipeline products. Positive results from the feasibility study could […]

Filed Under: Featured, Nanoparticles, Pharmaceuticals, Wall Street Beat Tagged With: leon-nanodrugs GmbH, Takeda Pharmaceutical Co

Ocugen launches Ph3 trial for eye disease nanoemulsion

July 2, 2018 By Sarah Faulkner

Ocugen logo

Ocugen said today that it launched the first of two pivotal Phase III trials for its OCU300 nanoemulsion designed to treat the symptoms of ocular graft versus host disease. The Malvern, Penn.-based company’s drug is a nanoemulsion formulation of brimonidine tartrate made using Ocugen’s OcuNanoE technology. Ocugen touted that it’s the first company to bring […]

Filed Under: Clinical Trials, Featured, Nanoparticles, Optical/Ophthalmic, Pharmaceuticals Tagged With: ocugen

Precision NanoSystems raises $6m to fund nanomedicine manufacturing tech

June 8, 2018 By Sarah Faulkner

Precision NanoSystems

Vancouver-based Precision NanoSystems said today that it closed a $6m Series B round, with investments from 5AM Ventures, Telegraph Hill Partners and Rising Tide Fund. The company is slated to use its newly-acquired funds to support the expansion of its services, including its nanomedicine manufacturing platform, NanoAssemblr. Precision NanoSystems’ technology is designed to enable the […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Nanoparticles, Pharmaceuticals Tagged With: precisionnanosystems

MIT researchers devise single-injection delivery method for polio vaccine

May 22, 2018 By Sarah Faulkner

MIT polio vaccine

Although most of the world is protected from the polio virus thanks to a vaccine developed decades ago, some countries remain vulnerable to the disease thanks to challenges posed by a vaccine that requires repeat dosing. Researchers from the Massachusetts Institute of Technology want to change that with a nanoparticle vaccine that can deliver multiple […]

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology

Will medtech drive the next Southeastern U.S. industrial revolution?

April 30, 2018 By Chris Newmarker

South Carolina Southeastern U.S. medtech

Paul Snyder, Write2Market Once home to a thriving textile industry replete with chemical and mechanical engineers working to improve the soil and machinery converting raw cotton into commercial goods, upstate South Carolina may be on the precipice of its next industrial revolution: medtech. Born from technology developed at the Albert Einstein College of Medicine, Greenville-based […]

Filed Under: Business/Financial News, Featured, Nanoparticles Tagged With: alberteinsteincollegeofmedicine, clemsonuniversity, cubeinc, southcarolina, southeasternmedicaldeviceassociation, startups, write2market, zylotherapeutics

NanOlogy looks to transform chemotherapy with localized delivery platform

March 5, 2018 By Sarah Faulkner

NanOlogy

Paclitaxel revolutionized cancer treatment when it was first used as a chemotherapeutic in the 1990s. But although the product is a powerful cancer killer, patients taking systemic doses of paclitaxel have to endure side effects such as peripheral neuropathy and hair loss. Marc Iacobucci and his team at NanOlogy believe they could replace the need […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Nanoparticles, Oncology, Pharmaceuticals, Regulatory/Compliance, Research & Development, Wall Street Beat Tagged With: nanology

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 9
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS